Who owns Elevation Oncology Inc?
- Ticker: ELEV
- CUSIP Number: 28623u101
Tip: Access positions for across all investors
Analyze quarterly positions in Elevation Oncology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Elevation Oncology stock
Who bought or sold Elevation Oncology Inc this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Frazier Life Sciences Management | 6.0M | $3.6M | 103% | Sep 2024 |
|
Tang Capital Management | 4.8M | $2.9M | 56% | Sep 2024 |
|
Logos Global Management | 3.9M | $10M | 285% | Jun 2024 |
|
Farallon Capital Management | 3.6M | $9.7M | -7% | Jun 2024 |
|
BVF | 3.0M | $1.8M | 28% | Sep 2024 |
|
BlackRock | 2.9M | $1.7M | 100% | Sep 2024 |
|
Aisling Capital Management | 2.8M | $7.7M | 0% | Jun 2024 |
|
BlackRock | 2.5M | $6.7M | 1349% | Jun 2024 |
|
Balyasny Asset Management | 2.5M | $6.7M | -19% | Jun 2024 |
|
Vanguard Group | 1.9M | $5.2M | 25% | Jun 2024 |
|
Renaissance Technologies | 1.8M | $1.1M | 100% | Sep 2024 |
|
Hudson Bay Capital Management | 1.4M | $815k | -43% | Sep 2024 |
|
Palo Alto Investors | 1.3M | $779k | -28% | Sep 2024 |
|
Morgan Stanley | 1.3M | $3.4M | 4437% | Jun 2024 |
|
Geode Capital Management | 1.1M | $666k | 8% | Sep 2024 |
|
OrbiMed Advisors | 941k | $565k | 0% | Sep 2024 |
|
State Street Corporation | 897k | $2.4M | 711% | Jun 2024 |
|
Ikarian Capital | 690k | $414k | 0% | Sep 2024 |
|
Acadian Asset Management | 652k | $390k | 100% | Sep 2024 |
|
Ghost Tree Capital | 600k | $1.6M | 140% | Jun 2024 |
|
Schonfeld Strategic Advisors | 543k | $326k | 41% | Sep 2024 |
|
Goldman Sachs Group | 504k | $1.4M | -9% | Jun 2024 |
|
Braidwell | 474k | $284k | -81% | Sep 2024 |
|
GSA Capital Partners | 434k | $260k | 100% | Sep 2024 |
|
Northern Trust | 373k | $224k | 476% | Sep 2024 |
|
Sphera Funds Management | 330k | $891k | -23% | Jun 2024 |
|
AQR Capital Management | 161k | $97k | 100% | Sep 2024 |
|
Qube Research & Technologies | 132k | $356k | -8% | Jun 2024 |
|
Bridgeway Capital Management | 128k | $346k | 20% | Jun 2024 |
|
Charles Schwab Investment Management | 124k | $75k | -8% | Sep 2024 |
|
Bank of New York Mellon | 124k | $74k | -19% | Sep 2024 |
|
Millington Financial Advisors | 100k | $60k | 100% | Sep 2024 |
|
Nuveen Asset Management | 81k | $219k | 100% | Jun 2024 |
|
Barclays | 72k | $43k | 302% | Sep 2024 |
|
Rhumbline Advisers | 65k | $39k | 0% | Sep 2024 |
|
Jpmorgan Chase & Co | 61k | $37k | 176% | Sep 2024 |
|
Two Sigma Investments | 60k | $161k | 100% | Jun 2024 |
|
Alpine Partners VI | 50k | $135k | 100% | Jun 2024 |
|
SG Americas Securities | 46k | $28k | 100% | Sep 2024 |
|
Bank of America Corporation | 40k | $24k | -78% | Sep 2024 |
|
Citigroup | 40k | $24k | 245% | Sep 2024 |
|
Jane Street | 30k | $18k | -41% | Sep 2024 |
|
Deutsche Bank Aktiengesellschaft | 29k | $17k | 0% | Sep 2024 |
|
Citadel Advisors | 28k | $17k | -34% | Sep 2024 |
|
Mirae Asset Global Etfs Holdings | 27k | $16k | 100% | Sep 2024 |
|
Leucadia National Corporation | 25k | $68k | 37% | Jun 2024 |
|
Invesco | 24k | $15k | -1% | Sep 2024 |
|
Dynamic Technology Lab Private | 22k | $59k | 100% | Jun 2024 |
|
Simplex Trading | 20k | $11k | 13165% | Sep 2024 |
|
Wells Fargo & Company | 19k | $12k | 0% | Sep 2024 |
|
Squarepoint Ops | 18k | $49k | -74% | Jun 2024 |
|
Palumbo Wealth Management | 18k | $11k | 55% | Sep 2024 |
|
T. Rowe Price Associates | 17k | $11k | 0% | Sep 2024 |
|
Engineers Gate Manager | 14k | $8.2k | 100% | Sep 2024 |
|
Tower Research Capital | 11k | $30k | 47726% | Jun 2024 |
|
Mercer Global Advisors | 11k | $28k | 100% | Jun 2024 |
|
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 9.7k | $5.8k | 0% | Sep 2024 |
|
Royal Bank of Canada | 5.4k | $0 | 10% | Sep 2024 |
|
New York State Common Retirement Fund | 5.2k | $3.0k | -87% | Sep 2024 |
|
Summit Investment Advisors | 5.1k | $3.1k | 0% | Sep 2024 |
|
California State Teachers Retirement System | 3.8k | $2.3k | 0% | Sep 2024 |
|
Advisor Group Holdings | 2.0k | $1.2k | -33% | Sep 2024 |
|
Amalgamated Bank | 1.8k | $999.970000 | 0% | Sep 2024 |
|
CWM | 429.00 | $0 | 100% | Sep 2024 |
|
NISA Investment Advisors | 147.00 | $87.994200 | 100% | Sep 2024 |
|
Group One Trading | 100.00 | $60.000000 | 100% | Sep 2024 |
|
Sterling Capital Management | 98.00 | $58.996000 | 100% | Sep 2024 |
|
Capital Performance Advisors | 11.00 | $7.000400 | 100% | Sep 2024 |
|
Who sold out of Elevation Oncology?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
venBio Partners | Jun 2024 | 2.4M | $6.6M |
Darwin Global Management | Jun 2024 | 1.9M | $4.8M |
Point72 Asset Management | Jun 2024 | 1.7M | $4.5M |
Affinity Asset Advisors | Jun 2024 | 1.5M | $4.0M |
Artal Group | Jun 2024 | 1.0M | $2.7M |
Octagon Capital Advisors | Jun 2024 | 747k | $2.0M |
Exome Asset Management | Jun 2024 | 369k | $997k |
Dimensional Fund Advisors | Jun 2024 | 73k | $197k |
Jump Financial | Jun 2024 | 50k | $134k |
American Century Companies | Jun 2024 | 49k | $133k |
XTX Topco | Jun 2024 | 38k | $103k |
Marshall Wace | Jun 2024 | 38k | $102k |
Ing Investment Management | Jun 2024 | 19k | $50k |
Ameritas Advisory Services | Jun 2024 | 16k | $42k |
MetLife Investment Advisors | Jun 2024 | 15k | $39k |
Marathon Trading Investment Management | Jun 2024 | 14k | $37k |
Macquarie Group | Mar 2024 | 1.3k | $7.007000 |